SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

US markets end mostly higher on Monday

10 Nov 2020 Evaluate

The US markets ended mostly higher on Monday following upbeat results from a phase 3 study of the coronavirus vaccine being developed by Pfizer (PFE) and BioNTech (BNTX). Pfizer and BioNTech said an interim analysis of the results found the vaccine candidate to be more than 90 percent effective in preventing COVID-19 in participants without evidence of prior infection. Pfizer Chairman and CEO Dr. Albert Bourla said today is a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine's ability to prevent COVID-19. The companies said they plan to submit the vaccine for regulatory approval in the US and Europe soon after the required safety milestone is achieved, which is currently expected to occur in the third week of November.

The vaccine reports added to positive sentiment generated in reaction to the weekend’s news that Democratic candidate Joe Biden’s is projected to win the presidential election. Besides, several major reports organizations called the race for Biden on Saturday after projecting the former Vice President will win Pennsylvania and its 20 electoral votes. The apparent victory for Biden potentially sets up a divided government, with control of the Senate likely to be decided by two run-off elections in Georgia. However, President Donald Trump has refused to concede the race, alleging widespread voter fraud and launching legal challenges in several key states.

Dow Jones Industrial Average rose 834.57 points or 2.95 percent to 29,157.97 and S&P 500 was up by 41.06 points or 1.17 percent 3,550.5, while Nasdaq dropped 181.45 points or 1.53 percent to 11,713.78.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: